Data / Form D filings / Antares Therapeutics, Inc.
Antares Therapeutics, Inc.: Form D filings
Antares Therapeutics, Inc., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC in 2025. The latest, on May 15, 2025, reports $30 million sold of a $136.7 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE WINTHROP SQUARE, SUITE 400, Boston, MA, 02110
- Phone
- (781) 288-5760
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2059043
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | New notice | $136,650,000 | $30,000,000 | $106,650,000 | 35 | May 1, 2025 | sec.gov |
| Mar 12, 2025 | New notice | $40,000,000 | $40,000,000 | 3 | Mar 5, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Fedder | Executive Officer | |
| Menelas N. Pangalos | Director | |
| Jeffrey Albers | Director | |
| Keith Flaherty | Director | |
| Jean-Francois Formela | Director | |
| Adam Friedman | Executive Officer, Director | |
| Brian Piper | Executive Officer | |
| Shelley Chu | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 12, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Antares Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.